VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $709,000 | -89.9% | 48,900 | -83.0% | 0.00% | -85.2% |
| Q3 2016 | $7,054,000 | -16.4% | 287,430 | -31.3% | 0.03% | -18.2% |
| Q2 2016 | $8,436,000 | -72.9% | 418,330 | -64.7% | 0.03% | -73.8% |
| Q1 2016 | $31,132,000 | -76.9% | 1,183,740 | -10.9% | 0.13% | -78.2% |
| Q4 2015 | $135,033,000 | -25.4% | 1,328,610 | +31.0% | 0.58% | -24.0% |
| Q3 2015 | $181,020,000 | -4.3% | 1,013,994 | +18.9% | 0.76% | +5.7% |
| Q2 2015 | $189,138,000 | +16.5% | 852,582 | +3.7% | 0.72% | +16.4% |
| Q1 2015 | $162,396,000 | +40.1% | 821,882 | +1.7% | 0.62% | +47.3% |
| Q4 2014 | $115,884,000 | -44.9% | 808,532 | -49.7% | 0.42% | -44.3% |
| Q3 2014 | $210,502,000 | +14.5% | 1,606,190 | +10.5% | 0.75% | +19.4% |
| Q2 2014 | $183,920,000 | +104.5% | 1,454,090 | +112.7% | 0.63% | +95.0% |
| Q1 2014 | $89,939,000 | +2.4% | 683,479 | -8.7% | 0.32% | +1.9% |
| Q4 2013 | $87,844,000 | +16.8% | 748,879 | +3.9% | 0.32% | +11.2% |
| Q3 2013 | $75,188,000 | +18.1% | 720,969 | -2.3% | 0.28% | +10.9% |
| Q2 2013 | $63,664,000 | – | 737,669 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |